 mainten therapi sucralf duoden ulcer genuin prevent heal ulcer recurr efficaci sucralf prevent duoden ulcer recurr efficaci sucralf due true reduct ulcer preval due secondari effect analges activ heal double-blind placebo-control parallel group clinic studi patient patient past histori duoden ulcer ulcer endoscop examin month start studi complet ulcer eros studi sucralf placebo tablet day month ulcer recurr endoscop month symptom presenc absenc duoden ulcer patient ulcer visit patient sucralf tablet day next schedul visit statist analys result efficaci sucralf placebo duoden ulcer recurr comparison therapeut agent duoden ulcer statist differ cumul rate ulcer follow-up period time detect statist expert unit food drug administr fda fda advisori panel doubt clinic studi result type analysi possibl mechan number observ ulcer analges effect heal true ulcer prevent tradit ulcer analysi ulcer due analges effect heal point-preval analysi ulcer due acceler heal endoscop examin maximum ulcer analys novel statist method analges effect endoscopi heal ulcer frequent endoscopi open-label phase maximum ulcer analysi true ulcer recurr prevent sucralf superior ulcer preval analys signific month analys month signific tradit analysi month point-preval analysi month maxim ulcer preval analysi sucralf effect prevent duoden ulcer recurr true reduct new ulcer develop